Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Earp et al v. Novartis Pharmaceuticals Corporation
Case Number:
5:11-cv-00680
Court:
Nature of Suit:
Judge:
Firms
-
May 14, 2014
Novartis Prevails In Bone Drug Trial In NC
A North Carolina federal jury found Wednesday that Novartis Pharmaceutical Corp.'s failure to provide an adequate warning regarding the use of its bone drugs Zometa and Aredia didn't proximately cause a user's jaw injury, handing the company another victory in a far-reaching product liability battle over the drugs.
-
May 12, 2014
Novartis Gets Punitive Damages Barred In Bone Drug Suit
A North Carolina federal judge overseeing a trial over jaw injuries allegedly caused by Novartis Pharmaceutical Corp.'s bone drugs Zometa and Aredia on Friday said the company can't be held liable for punitive damages because there isn't enough evidence to prove its executives acted wrongfully.